Stage FocusSeed, Series A, Series B+
GeographyEurope
TypeCVC
Last Activity2026
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
Servier Ventures launched in January 2026 as the first CVC initiative for Servier, France's largest private pharmaceutical company. The commitment is €200M (roughly $234M) to the European biotech sector, focused on oncology and neurology therapeutics aligned with Servier's core therapeutic areas.
The fund takes minority stakes in innovative biotech and technology companies, with an initial Europe...
Similar Funds
AP
Auriga Partners
Paris, France
GeneralistBiotechCybersecurityMedtechSeedSeries A
HV
Hummingbird VC
London, United Kingdom
GeneralistBiotechAIBlockchainPre-SeedSeed
I
Innovestor
Helsinki, Finland
GeneralistBiotechMedtechEnergy TechPre-SeedSeed
IP
InterWest Partners
Menlo Park, California, United States
GeneralistBiotechMedtechSemiconductorsSeedSeries A
NP
Naxicap Partners
France
GeneralistBiotechMedtechSeedSeries A
Novartis Venture Fund
Basel, Switzerland
GeneralistBiotechMedtechSeedSeries A